Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that it has been notified by United States Food and Drug Administration("FDA") that its pending application for KADIAN(R) 80mg capsule has received approval. The company expects to launch this new dosage strength in the fourth quarter of 2006. [click link for full article]

[News Source]